仅用于工业应用或科学研究，不可用于人类或动物的临床诊断或治疗，非药用. Idarucizumab is a humanized monoclonal antibody fragment. Idarucizumab is first reversal agent for a direct oral anticoagulant （DOAC）. Idarucizumab can specifically neutralize the effects of the oral direct thrombin inhibitor in order to restore hemostasis